{
    "code": "02023129",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023129",
    "time": "2016-11-18 20:18:41",
    "許可證字號": "衛署藥輸字第023129號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/16",
    "註銷理由": "屆期未申請展延",
    "有效日期": "95\/02\/20",
    "發證日期": "90\/02\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202312909",
    "中文品名": "優立納錠",
    "英文品名": "URINARON TABLETS",
    "適應症": "神經性頻尿、慢性前列腺炎、慢性膀胱炎伴隨的頻尿、殘尿感。",
    "劑型": "116膜衣錠",
    "包裝": "鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "FLAVOXATEHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1427601100  瑪里士實業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260330000  TAKESHIMA PHARMACEUTICAL CO., LTD.",
        "製造廠廠址": "7-5 MINAMISAKAE-CHO, KASUKABE, SAITAMA-KEN.7-11, 4-CHOME, KOMAGOME, TOSHIMA-KU,TOKYO 170,JAPAN.",
        "製造廠公司地址": "7-11, 4-CHOME, KOMAGOME, TOSHIMA-KU,TOKYO 170,JAPAN.",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002310",
            "成分名稱": "FLAVOXATE HCL",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}